NAFTA Tribunal Sides With FDA Against Apotex Suit Over Import Bans

Drug Industry Daily
A A
Canadian generics maker Apotex has lost a $520 million lawsuit the company brought in front of an international arbitration board against the FDA over import alerts on two of its facilities.

To View This Article:

Login

Subscribe To Drug Industry Daily